29th Annual North American Cystic Fibrosis Conference

S17: NT: Strategies for Rare CFTR Mutations

Oct 10, 2015 2:30pm ‐ Oct 10, 2015 4:20pm

Standard: $49.99

Description

Among 80,000 CF patients worldwide, almost 2,000 CFTR variants have been reported. However, the molecular mechanisms that underlie the physiologic consequences for the majority of these rare variants are unknown. This session will detail our current understandings & approaches to restoring the function of these rare, non-F508del CFTR variants.

Educational Objectives:

  1. Describe how rare mutations cause CFTR dysfunction using genetic & cell biological approaches.
  2. Describe the approach to developing novel, mechanism based small molecule therapeutic options to treat patients with rare mutations in a personalized fashion.
  3. Describe the uses of induced pluripotent stem cells & gene editing strategies in targeted correction & restoration of CFTR function.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content